AzTrials
AzTrials

MyopiaLightSPANNCT06631339

Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN)

A study testing Light Intervention and Digital Intervention in people with Myopia and Light; Therapy, Complications, run by National University of Singapore at 5 sites in Singapore.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to evaluate whether the optimization of daily exposure to light in primary school children can lead to better myopia prevention and control. The trial also aims to better understand the impact of light exposure on sleep and cognitive performance in children. Read more about this study

Who is it for?
Ages 7 to 10 yearsHealthy volunteers can take part
What is being tested?
Light Intervention and Digital Intervention
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
396 participants
Where
5 sitesSingapore
Study dates
21 Oct 2024to 26 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Subject must meet all the inclusion criteria below to participate in this study.
  • Written Informed Consent form from parent / legal guardian and assent from child subject has been obtained
  • Is between 7 to 10 years of age at start of study intervention which is 2 January 2025 or 1 January 2026
  • Studying in either Primary 2 or 3 classes of the participating school(s) in academic year 2025 or 2026.
  • Presenting visual acuity or best corrected visual acuity (BCVA) better or equal to LogMAR 0.2 (equivalent to Snellen 6/9 or better) in each eye
  • Normal Intraocular pressure (not more than 21mmHg)
Show all 9Show fewer
  • No ocular conditions (e.g., optic nerve disease, glaucoma, retinal diseases) except for refractive error.
  • No ocular conditions affecting the accuracy of the ophthalmic examinations
  • In good general health with no significant systemic diseases that may affect eye health

Who cannot join

  • All subjects meeting any of the exclusion criteria at baseline will be excluded from participation.
  • Previous or ongoing myopia control treatment (including but not limited to orthokeratology, atropine, pirenzepine, myopia control spectacle and contact lenses, light therapy)
  • Ongoing participation in other myopia prevention and control research trials
  • Any systemic or neurologic diseases (e.g. cancer, epilepsy, Kawasaki disease) known to affect eye health or make the participant vulnerable to the ophthalmic examinations (e.g., light flash)
  • Any other conditions precluding adherence to the protocol including unwillingness to refrain from myopia control treatment for the duration of the study

Trial locations and contacts

5 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Raymond P. Najjar, PhD contact

006566018519

lightspan@nus.edu.sg

5 sites in 1 country

Singapore5 sites, 5 recruiting
  • National University of Singapore, Yong Loo Lin School of Medicine, Department of Ophthalmology, Eye N Brain Research Lab

    Singapore, 119276

    Najiya Sundus Kadavath Meethal, PhD, 006591183642, lightspan@nus.edu.sg

    Raymond P. Najjar, PhD

    Recruiting
  • Marymount Convent School

    Singapore, 297754

    Najiya Sundus Kadavath Meethal, PhD, 006591183642, lightspan@nus.edu.sg

    Raymond P. Najjar, PhD

    Recruiting
  • Bedok Green Primary School

    Singapore, 469317

    Najiya Sundus Kadavath Meethal, PhD, 006591183642, lightspan@nus.edu.sg

    Raymond P Najjar, PhD

    Recruiting
  • Westwood Primary School

    Singapore, 649188

    Najiya Sundus Kadavath Meethal, PhD, 006591183642, lightspan@nus.edu.sg

    Raymond P Najjar, PhD

    Recruiting
  • Wellington Primary School

    Singapore, 757702

    Najiya Sundus Kadavath Meethal, PhD, 006591183642, lightspan@nus.edu.sg

    Raymond P Najjar, PhD

    Recruiting

Other trials in Singapore

About this study

The goal of this clinical trial is to evaluate whether the optimization of daily exposure to light in primary school children can lead to better myopia prevention and control. The trial also aims to better understand the impact of light exposure on sleep and cognitive performance in children.

This trial has 3 arms namely, (1) a technical intervention arm, (2) a digital intervention arm, and (3) a control arm.

Read more
  1. technical intervention - which involves changing of classroom lighting in primary schools to ceiling lights that mimic the spectral composition of sunlight and fluctuates in intensity. Parents of children within that arm will have a sham smart-phone application (s-LightUP)
  2. digital intervention - which involves standard classroom lighting and giving parents an interventional smart-phone application (i-LightUP) that will be coupled with their child's light and activity sensor (wrist worn device ). The interventional app will provide individually tailored recommendation based on their children's behaviour (data feedback that is collected from the light and activity monitoring watch). The interventional app would then send reminder prompts/notifications to encourage parents help their children achieve required amounts of myopia-preventive light quantum target set per day.
  3. Standard care or control group which involves standard classroom lighting and parents having a sham smart-phone application (s-LightUP)

Participants will:

  • be randomised to receive either no intervention (control group), technical intervention (light intervention that mimics sunlight) or digital intervention (parents having an app that syncs with child's light and activity sensor which will provide feedback to parents to encourage and recommends increment of outdoor activities and hours).
  • have their myopia progression monitored every 6 monthly and cognitive assessment done once every 3 months over a year.
  • wear the light and activity sensor watches throughout the 1-year study period as much as possible (minimum 1 week per month) except for wet water activities such as swimming, diving and showering for research data collection purpose.
Read the detailed description

The primary objective of the study is to evaluate whether the optimization of daily exposure to light in primary school children can lead to better myopia prevention and control. To do so, we will evaluate the effectiveness, safety and feasibility of:

  1. Arm 1: technical intervention which involves spectro-temporal refinement of classroom lighting in primary schools using full spectrum light emitting diodes (LEDs) (CCT: 4000K) in addition to intermittent fluctuations in light levels. Parents of children in that arm will have access to a sham version of the LightUP mobile application to facilitate communication with the study team and questionnaire collection during the study.
  2. Arm 2: digital intervention which involves optimization of daily light exposure using an individualised behaviour-changing smart-phone application (Interventional LightUP application) coupled with child-worn light and activity sensors to provide parents with an individually tailored recommendation to adapt their children's behaviour and provide them with the required amounts of myopia-preventive light quantum/day. + standard classroom lighting As compared to:
  3. Arm 3: Standard care or control group which involves standard classroom lighting and no access to the interventional version of the LightUP application. Parents of children in that arm will have access to a sham version of the LightUP mobile application to facilitate communication with the study team and questionnaire collection during the study.

Our study will also lead to the following scalable and implementable outcomes:

  1. evidence-based lighting designs and policy recommendations for classrooms;
  2. a user-friendly, smart digital eyecare companion that aligns perfectly with Singapore's Smart Nation Initiative.

A secondary objective of this study is to better understand the impact of light exposure on sleep and cognitive performance in children. This will be achieved through continuous wrist actigraphy monitoring and through cognitive assessments, performed in classrooms, using tablets (one tablet/child). The assessment consists of validated, child-adapted, higher cognitive tasks testing the following constructs: impulse control, spatial working memory, content working memory, cognitive flexibility, reaction time, and processing speed.

Being tested
Light Intervention, Digital Intervention, Control Group
Keywords
Light Exposure, Digital Intervention, Myopia, Myopia Prevention, Cognition, Light Intervention, Behaviour changing phone application, Classroom, School-based, School, Singapore, Primary School, Light therapy, Myopia-control
Medical subject headings
Myopia, Refractive Errors

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Light InterventionOther

    LEDs mimicking the spectrum of sunlight (4000K) administered daily for 1 academic year, every school day, for the entire school day. The light levels generated by these LEDs will fluctuate throughout the day but will remain under 1000 lux.

  • Digital InterventionBehavioural

    Smart-phone application (LightUP) will be synced daily to a child-worn light and activity sensor and will allow parents to track their children's outdoor time and exposure to brighter light levels across the day. The application will also nudge parents to increase their child's exposure to light (e.g., increase time outdoors, or sitting next to a window indoors) after school hours for better myopia prevention and control. i-LightUP aims to gradually assist parents in helping their children reach the ultimate goal of spending at least 2 hours per day in brighter light conditions (e.g., above 1000 lux).

  • Control GroupOther

    Standard Classroom Lighting + Sham LightUP phone application

Study groups in NCT06631339
Study groupRoleWhat they receive
Technical Intervention (n=132)ExperimentalTechnical refinement of classroom lighting + Sham LightUP phone application (s-LightUP)
Receives: Other: Light Intervention
Digital Intervention (n=132)ExperimentalStandard classroom lighting + Interventional LightUP phone application (i-LightUP)
Receives: Behavioral: Digital Intervention
Control Group (n=132)Placebo comparatorStandard care or control group which involves standard classroom lighting + Sham LightUP app (s-LightUP).
Receives: Other: Control Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cycloplegic auto-refraction

    Measured using autoref/kerato/pachy/tonometer

    Measured: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

  2. Axial Length

    Measured using non-contact optical biometer

    Measured: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

  3. Choroidal Thickness

    Measured using optical coherence tomography (OCT) scan

    Measured: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Secondary outcomes (13)
  1. Retinal and choroidal perfusion

    Measured using optical coherence tomography angiography (OCT-A) function within OCT machine used to measure choroidal thickness.

    Measured: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

  2. Corneal Curvature

    Measured using autoref/kerato/pachy/tonometer.

    Measured: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

  3. Corneal Thickness

    Measured using autoref/kerato/pachy/tonometer.

    Measured: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

  4. Impulse control

    Impulse control will be assessed using a validated, child-adapted task developed by collaborator Dr. Evelyn Law (NUS). The "Day and Night Cards" task or a similar task will be administered on tablets (one tablet per child). Impulse control will be quantified by the number of errors committed by the children during the task which involves shifting instructions and paradigms.

    Measured: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

  5. Cognitive flexibility

    Cognitive flexibility will be assessed using a validated, child-adapted task developed by collaborator Dr. Evelyn Law (NUS). The "Day and Night Cards" task or a similar task will be administered on tablets (one tablet per child). Cognitive flexibility will be quantified by the number of errors committed by the children during the task which involves shifting instructions and paradigms.

    Measured: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

  6. Spatial working memory

    Spatial working memory will be assessed using a validated, child-adapted task developed by collaborator Dr. Evelyn Law (NUS). The "Eight Boxes" task or a similar task will be administered on tablets (one tablet per child). Spatial working memory will be quantified by the number of errors committed by the children during the task.

    Measured: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

  7. Content working memory

    Content working memory will also be assessed using a validated, child-adapted task developed by collaborator Dr. Evelyn Law (NUS). The "Eight Boxes" task or a similar task will be administered on tablets (one tablet per child). Content working memory will be quantified by the number of errors committed by the children during the task when remembering the content of different items in the task (e.g., strawberry, watermelon, etc.).

    Measured: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

  8. Processing speed

    Processing speed will be assessed from the previous cognitive tasks (e.g., Eight Boxes and Day and Night Cards" through the investigation of reaction time (ms) in response to the content of the tasks. The tasks will be administered on tablets (one tablet per child).

    Measured: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

  9. Sleep quantity

    This is a secondary outcome and will depend on the days of wear of the activity and light trackers. Night time sleep quantity (minutes) will be collected through actigraphy watches given to participants.

    Measured: 1 year or at least 1 week per month for 1 year

  10. Sleep efficiency

    This is a secondary outcome and will depend on the days of wear of the activity and light trackers. Night time sleep efficiency (%) calculated as the amount of time spent asleep (in minutes) by the total amount of time in bed (in minutes) will be measured using actigraphy watches given to participants.

    Measured: 1 year or at least 1 week per month for 1 year

  11. Height

    Height of the participant in cm

    Measured: 1 year, at baseline and 12 months from baseline

  12. Weight

    Weight of the participant in Kg

    Measured: 1 year, at baseline and 12 months from baseline

  13. Visual acuity

    LogMAR visual acuity test

    Measured: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2024
  2. Study start21 Oct 2024
  3. Primary completion26 Jan 2027 (estimated)
  4. Study completion26 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Primary School-based, 12-Month, semi-randomised, controlled, double-blinded, 3 study arm (n=132 per arm) trial.
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
396 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06631339
Sponsor's protocol ID
NUS-IRB-2023-767
Acronym
LightSPAN
Status last verified
Sep 2025
First submitted
1 Oct 2024
Last updated
23 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Light Intervention and Digital Intervention in people with Myopia and Light; Therapy, Complications, run by National University of Singapore at 5 sites in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Raymond P. Najjar, PhD (006566018519, lightspan@nus.edu.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cycloplegic auto-refraction (time frame: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
LightSPAN Clinical Trial NCT06631339 | AzTrials